Raelipskie Partnership’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95K Hold
25
﹤0.01% 103
2025
Q4
$4.1K Hold
25
﹤0.01% 97
2025
Q3
$3.34K Hold
25
﹤0.01% 101
2025
Q2
$3.11K Hold
25
﹤0.01% 102
2025
Q1
$3.18K Hold
25
﹤0.01% 102
2024
Q4
$3.6K Hold
25
﹤0.01% 102
2024
Q3
$3.72K Hold
25
﹤0.01% 110
2024
Q2
$3.15K Hold
25
﹤0.01% 88
2024
Q1
$4.6K Hold
25
﹤0.01% 87
2023
Q4
$4.5K Buy
+25
New +$3.89K ﹤0.01% 83

Other funds holding RGEN

Raelipskie Partnership's RGEN Position: Q1 2026 in Review

Raelipskie Partnership held its Repligen (RGEN) position steady in Q1 2026 at 25 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #103.

Raelipskie Partnership first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.6K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Raelipskie Partnership held 25 shares of Repligen worth $2.95K as of Q1 2026.
  • Raelipskie Partnership left its Repligen share count unchanged in Q1 2026.
  • Repligen made up ﹤0.01% of Raelipskie Partnership's portfolio in Q1 2026, its #103 holding.
  • Raelipskie Partnership first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
  • Raelipskie Partnership's Repligen position peaked at $4.6K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.